Article ; Online: Combination Treatment of Cervical Cancer Using Folate-Decorated, pH-Sensitive, Carboplatin and Paclitaxel Co-Loaded Lipid-Polymer Hybrid Nanoparticles.
Drug design, development and therapy
2020 Volume 14, Page(s) 823–832
Abstract: Purpose: Cervical cancer is one of the most common causes of death among women globally. Combinations of cisplatin, paclitaxel, bevacizumab, carboplatin, topotecan, and gemcitabine are recommended as first-line therapies.: Methods: This study focuses ...
Abstract | Purpose: Cervical cancer is one of the most common causes of death among women globally. Combinations of cisplatin, paclitaxel, bevacizumab, carboplatin, topotecan, and gemcitabine are recommended as first-line therapies. Methods: This study focuses on the development of folate-decorated, pH-sensitive lipid-polymer hybrid nanoparticles (LPNs). Loading carboplatin (CBP) and paclitaxel (PTX), LPNs were expected to combine the therapeutic effects of CBP and PTX, thus show synergistic ability on cervical cancer. Results: FA-CBP/PTX-LPNs showed the sizes of 169.9 ± 5.6 nm, with a narrow size distribution of 0.151 ± 0.023. FA-CBP/PTX-LPNs exhibited pH-responsive drug release, high cellular uptake efficiency (66.7 ± 3.1%), and prominent cell inhibition capacity (23 ± 1.1%). In vivo tumor distribution and tumor inhibition efficiency of FA-CBP/PTX-LPNs was the highest, with no obvious body weight lost. Conclusion: High tumor distribution and remarkable antitumor efficiency obtained using in vitro as well as in vivo models further proved the FA-CBP/PTX-LPNs is a promising tool for cervical cancer therapy. |
---|---|
MeSH term(s) | Animals ; Antineoplastic Agents/administration & dosage ; Antineoplastic Agents/pharmacology ; Carboplatin/administration & dosage ; Carboplatin/pharmacology ; Cell Proliferation/drug effects ; Cell Survival/drug effects ; Combined Modality Therapy ; Dose-Response Relationship, Drug ; Drug Liberation ; Drug Screening Assays, Antitumor ; Female ; Folic Acid/administration & dosage ; Folic Acid/pharmacology ; HeLa Cells ; Humans ; Hydrogen-Ion Concentration ; Ligands ; Lipids/chemistry ; Mice ; Mice, Inbred BALB C ; Mice, Nude ; Molecular Structure ; Nanoparticles/administration & dosage ; Nanoparticles/chemistry ; Neoplasms, Experimental/drug therapy ; Neoplasms, Experimental/pathology ; Paclitaxel/administration & dosage ; Paclitaxel/pharmacology ; Polymers/chemistry ; Structure-Activity Relationship ; Uterine Cervical Neoplasms/drug therapy ; Uterine Cervical Neoplasms/pathology |
Chemical Substances | Antineoplastic Agents ; Ligands ; Lipids ; Polymers ; Folic Acid (935E97BOY8) ; Carboplatin (BG3F62OND5) ; Paclitaxel (P88XT4IS4D) |
Language | English |
Publishing date | 2020-02-26 |
Publishing country | New Zealand |
Document type | Journal Article |
ZDB-ID | 2451346-5 |
ISSN | 1177-8881 ; 1177-8881 |
ISSN (online) | 1177-8881 |
ISSN | 1177-8881 |
DOI | 10.2147/DDDT.S235098 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.